Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05914714
What this trial is testing

Ruxolitinib as GVHD Prophylaxis in AA Patients

Who this might be right for
The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
Institute of Hematology & Blood Diseases Hospital, China 46
Early research (Phase 1)Study completedNCT04456634
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine

Who this might be right for
Malaria
Medicines for Malaria Venture 8
Testing effectiveness (Phase 2)Looking for participantsNCT07509749
What this trial is testing

Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)

Who this might be right for
GVHD, AcuteStem Cell Transplant Complications
Daihong Liu 54
Large-scale testing (Phase 3)Study completedNCT03112603
What this trial is testing

Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 330
Testing effectiveness (Phase 2)Ended earlyNCT01562873
What this trial is testing

Ruxolitinib in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 21
Testing effectiveness (Phase 2)UnknownNCT02912754
What this trial is testing

Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Sunnybrook Health Sciences Centre 36
Not applicableUnknownNCT05566535
What this trial is testing

Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice

Who this might be right for
Polycythemia Vera
Multinational Center for Quality of Life Research, Russia 32
Not applicableAvailableNCT04745637
What this trial is testing

Managed Access Programs for INC424, Ruxolitinib

Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Thrombocythemia Myelofibrosis (PET-MF)+4 more
Novartis Pharmaceuticals
Not applicableStudy completedNCT05410470
What this trial is testing

Efficacy and Safety of Ruxolitinib in Patients With Myelofibrosis

Who this might be right for
Myelofibrosis
Qilu Hospital of Shandong University 130
Testing effectiveness (Phase 2)Looking for participantsNCT06756061
What this trial is testing

Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity

Who this might be right for
GVHD - Graft-Versus-Host DiseaseNeoplasmsHaematopoietic Stem Cell Transplantation
Byung-Sik Cho 88
Early research (Phase 1)Study completedNCT01702064
What this trial is testing

Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 11
Large-scale testing (Phase 3)Study completedNCT04057573
What this trial is testing

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

Who this might be right for
Non-segmental Vitiligo
Incyte Corporation 344
Large-scale testing (Phase 3)Study completedNCT02913261
What this trial is testing

Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation

Who this might be right for
Corticosteroid Refractory Acute Graft vs Host Disease
Novartis Pharmaceuticals 310
Not applicableStudy completedNCT06078319
What this trial is testing

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

Who this might be right for
Adherence, PatientAdherence, Treatment
IRCCS Azienda Ospedaliero-Universitaria di Bologna 189
Testing effectiveness (Phase 2)Study completedNCT04218071
What this trial is testing

Actuate 1901: 9-ING-41 in Myelofibrosis

Who this might be right for
Myelofibrosis
Actuate Therapeutics Inc. 17
Testing effectiveness (Phase 2)Study completedNCT02164500
What this trial is testing

JAK-inhibition in Recurrent Classical Hodgkin Lymphoma

Who this might be right for
Recurrent Classical Hodgkin Lymphoma
University of Cologne 12
Testing effectiveness (Phase 2)Ended earlyNCT04097821
What this trial is testing

Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients

Who this might be right for
Myelofibrosis
Novartis Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT03041636
What this trial is testing

Ruxolitinib Phosphate in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUntreated Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 1
Not applicableLooking for participantsNCT07153666
What this trial is testing

A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo

Who this might be right for
Vitiligo
Peking University Third Hospital 170
Testing effectiveness (Phase 2)Study completedNCT00509899
What this trial is testing

Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

Who this might be right for
MyelofibrosisPolycythemia VeraThrombocytosis
Incyte Corporation 154
Next Page